Nerve Repair and Regeneration Market by Products (Nerve Conduits, Nerve Wraps, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, TENS, TMS), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) - Global Forecast to 2025
[167 Pages Report] The global nerve repair and regeneration market is expected to reach USD 9.7 billion by 2025 from USD 6.3 billion in 2020, at a CAGR of 9.1% .The growth in this market is driven by high incidence of nerve injuries, growing prevalence of neurological disorders, increasing geriatric population, and rising government support for neurologic disorders
COVID -19 Impact On The Nerve Repair And Regeneration Market
COVID-19 has disrupted healthcare services in most countries worldwide; the worst affected so far are the US, Russia, Spain, Italy, the UK, India, Germany, and Iran. Its impact on the nerve repair and regeneration market is expected to be concentrated on the biomaterials segment, as opposed to the neurostimulation & neuromodulation segment.
This is mainly due to possible reductions in the demand for biomaterials. They are used for peripheral nerve repair—nerve injuries from motor vehicle accidents, lacerations, penetrating trauma, stretching or crushing trauma and fractures, burns, and gunshot wounds. Vehicular accidents are the most common cause of peripheral nerve injuries—according to an article published in PubMed, vehicular motor accidents contributed, as etiological factors, 26% of the total peripheral nerve injuries. However, due to the restrictions enforced to control the spread of COVID-19, vehicular traffic has reduced greatly in intensity; as a consequence, so has the number of road accidents.
The market for neurostimulation and neuromodulation is also expected to be affected, although to a lesser extent. This is mainly due to the prioritization of COVID-19 patients; other ailments and procedures are not receiving as much attention or simply not being conducted on a large scale. Many hospitals are postponing these procedures.
Global Nerve Repair and Regeneration Market Dynamics
Driver: Rising geriatric population and subsequent growth in the prevalence of neurological disorders
The geriatric population is at a higher risk of neurologic disorders such as stroke, neuropathy, Alzheimer’s disease, and Parkinson’s disease. Their higher susceptibility makes geriatrics a key segment of the overall patient pool. As a result, the growth of this population segment will ensure a continued, intensified demand for nerve repair and regeneration for the treatment of neurological disorders.
According to the WHO, the global population aged 60 years and above was 962 million in 2017 and expected to rise to 2.1 billion in 2050. According to World Population Prospects (2019 Revision), by 2050, one in four persons residing in Europe and Northern America could be of 65 years or above. Consequently:
- According to the Alzheimer's Association (2020 estimates), the number of people above 65 years of age suffering from Alzheimer’s could reach 13.8 million by 2050 from 5.8 million in 2020.
- According to the Parkinson’s Foundation, disease incidence rises with age; only 4% of total cases are diagnosed before 50 years of age.
- According to Parkinson’s UK, in 2018, there were 145,519 people affected by the disease in the country. This is expected to cross 168,000 by 2025.
OPPORTUNITY: Emerging markets
Emerging countries such as India, China, and Brazil are expected to offer potential growth opportunities for market players during the forecast period. The huge population base, especially in India and China, is expected to be a major draw for companies in this market. This is bolstered by the rising incidence of neurological diseases like Alzheimer’s, Parkinson’s, and epilepsy. According to estimates published in PubMed, by 2030, 4.94 million people in China will be suffering from Parkinson’s, accounting for nearly half of the total number of patients globally. Furthermore, according to the World Bank, healthcare expenditure is increasing in these countries, supporting the growth of hospitals and ambulatory surgical centers in these countries. This is considered as a positive indicator for the market growth, as hospitals and ambulatory surgical centers are major end users of nerve repair and regeneration products.
Neurostimulation and Neuromodulation Devices segment to dominate the nerve repair and regeneration market in 2019
Based on product, the nerve repair and regenerationmarket is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment to dominate the during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement .
Direct nerve repair/neurorrhaphy segment to dominate the biomaterials application for nerve repair and regeneration market in 2019
Based on application, the biomaterials market is segmented into direct nerve repair/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market. This can be attributed to the increasing incidence of neurological disorders across the globe.
North America was the largest regional market for the nerve repair and regeneration in 2019
The nerve repair and regeneration market has been analyzed for North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America held the largest share of the market, followed by Europe. The rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in the region in this region are the major factors driving the growth of the nerve repair and regeneration market in North America.
Key Market Players
Key players in the nerve repair and regeneration market are Prominent players in the nerve repair and regeneration market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (Switzerland), Collagen Matrix, Inc. (US), KeriMedical (Switzerland), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(Germany), and GiMer Medical (Taiwan). Medtronic ranked first in the nerve repair and regeneration market in 2019. The company has a wide range of products for nerve repair and regeneration covering all major technologies of nerve repair and regenerations. Medtronic differentiates its products by branding them and launching new products in the field of nerve repair and regenerations. Product innovation is the one of the major goals of the company and the company launched innovative products over the last three years. For example, in 2020, the company received received CE approval for InterStim Micro neurostimulator and InterStim SureScan MRI leads — clearing the technologies for commercial sale and clinical use in Europe
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market size available for years |
2018–2025 |
|
Base year considered |
2018 |
|
Forecast period |
2020–2025 |
|
Forecast units |
Value (USD) |
|
Segments covered |
|
|
Geographies covered |
North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (China, Japan, India, and the RoAPAC), Latin America and Middle East & Africa |
|
Companies covered |
Twenty major players were covered, including |
This research report categorizes the nerve repair and regeneration market into the following segments and subsegments:
Product
- Neurostimulation and Neuromodulation Devices
- Internal Neurostimulation Devices
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- External Neurostimulation Devices
- TENS
- TMS
- RES
- Biomaterials
- Nerve Conduits
- Nerve Wraps
- Internal Neurostimulation Devices
Application
- Neurostimulation and Neuromodulation Applications
- Internal Neurostimulation and Neuromodulation Applications
- External Neurostimulation and Neuromodulation Applications
- Direct Nerve Repair/Neurorrhaphy
- Epineural Repair
- Perineural Repair
- Group Fascicular Repair
- Nerve Grafting
- Autografts
- Allografts
- Xenografts
- Stem Cell Therapy
By Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Recent Developments:
- In 2020, Medtronic received CE approval for InterStim Micro neurostimulator and InterStim SureScan MRI leads — clearing the technologies for commercial sale and clinical use in Europe
- In 2019, Boston Scientific received FDA approval for the Image Ready MRI for its Vercise Gevia Deep Brain Stimulation System
- In 2020, LivaNova entered into partnership with Verily (US) for evaluation of the effectiveness of Vagus Nerve Stimulation Therapy (VNS Therapy) for difficult-to-treat Depression (DTD)
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 23)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 NERVE REPAIR & REGENERATION MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES MADE
2 RESEARCH METHODOLOGY (Page No. - 27)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
FIGURE 5 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 ASSUMPTIONS FOR THE STUDY
FIGURE 8 NERVE REPAIR & REGENERATION MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
3 PREMIUM INSIGHTS (Page No. - 39)
3.1 NERVE REPAIR & REGENERATION MARKET OVERVIEW
3.2 NERVE REPAIR & REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4 MARKET OVERVIEW (Page No. - 42)
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
FIGURE 19 NERVE REPAIR AND REGENERATION MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
4.2.1 DRIVERS
4.2.1.1 High incidence of nerve injuries
4.2.1.2 Rising geriatric population and subsequent growth in the prevalence of neurological disorders
4.2.1.3 Rising government support for neurologic disorder research
FIGURE 20 FUNDING FOR RESEARCH BY THE NIH, US
4.2.2 OPPORTUNITIES
4.2.2.1 Emerging markets
FIGURE 21 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRICS, 2012-2016
4.2.2.2 Potential of stem cell therapy in nerve repair and regeneration
4.2.2.3 Rising research in the field of neurology
FIGURE 22 RESEARCH PAPERS PUBLISHED (2011-2019)
TABLE 1 INDICATIVE LIST OF NEUROMODULATION CLINICAL TRAILS
4.2.3 CHALLENGES
4.2.3.1 Donor-site morbidity
4.2.3.2 Difficulties in treating large nerve gaps
4.2.3.3 Stringent regulatory frameworks and time-consuming approval processes
FIGURE 23 US FDA PRE-MARKET APPROVALS (2013-2018)
4.2.3.4 Greater preference for drug therapies over nerve repair and regeneration products
4.2.3.5 Dearth of trained professionals
4.2.3.6 Product recalls
TABLE 2 MAJOR PRODUCT RECALLS
4.3 IMPACT OF COVID-19 ON THE NERVE REPAIR AND REGENERATION MARKET
5 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT (Page No. - 50)
5.1 INTRODUCTION
TABLE 3 NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
5.2 NEUROSTIMULATION AND NEUROMODULATION DEVICES
TABLE 4 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 5 NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.1 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES
TABLE 6 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 7 INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.1.1 Spinal cord stimulation devices
5.2.1.1.1 Increasing incidence of spinal cord injuries will support the growth of this product segment
TABLE 8 SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.1.2 Deep brain stimulation devices
5.2.1.2.1 Increasing incidence of neurodegenerative diseases among the geriatric population will drive market growth
TABLE 9 DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.1.3 Vagus nerve stimulation devices
5.2.1.3.1 Increasing incidence of epilepsy to support market growth
TABLE 10 VAGUS NERVE STIMULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.1.4 Sacral nerve stimulation devices
5.2.1.4.1 Increasing incidence of urological disorders to drive market growth
TABLE 11 SACRAL NERVE STIMULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.1.5 Gastric electrical stimulation devices
5.2.1.5.1 GES is mainly used for the treatment of GERD and gastroparesis
TABLE 12 GASTRIC ELECTRICAL STIMULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.2 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES
TABLE 13 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 14 EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.2.1 Transcutaneous electrical nerve stimulation devices
5.2.2.1.1 Extensive use in healthcare, low cost, and ease of use are supporting the growth of this segment
TABLE 15 TENS DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.2.2 Transcranial magnetic stimulation devices
5.2.2.2.1 Minimal patient discomfort associated with TMS is supporting the adoption of TMS devices
TABLE 16 TMS DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.2.2.3 Respiratory electric stimulation devices
5.2.2.3.1 Increasing incidence of spinal cord injuries to support market growth
TABLE 17 RES DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
5.3 BIOMATERIALS
TABLE 18 BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 19 BIOMATERIALS MARKET, BY REGION, 2018-2025 (USD MILLION)
5.3.1 NERVE CONDUITS
5.3.1.1 Increasing research in the field of nerve repair to support market growth
TABLE 20 NERVE CONDUITS MARKET, BY REGION, 2018-2025 (USD MILLION)
5.3.2 NERVE WRAPS
5.3.2.1 Increasing incidence of peripheral injuries to drive market growth
TABLE 21 NERVE WRAPS MARKET, BY REGION, 2018-2025 (USD MILLION)
6 NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION (Page No. - 63)
6.1 INTRODUCTION
6.2 NEUROSTIMULATION & NEUROMODULATION APPLICATIONS
TABLE 22 NERVE REPAIR AND REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION APPLICATIONS, BY TYPE, 2018-2025 (USD MILLION)
TABLE 23 NERVE REPAIR AND REGENERATION MARKET FOR NEUROSTIMULATION & NEUROMODULATION APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
6.2.1 INTERNAL NEUROSTIMULATION & NEUROMODULATION
6.2.1.1 Minimally invasive nature and reversibility have supported market growth
TABLE 24 INTERNAL NEUROSTIMULATION & NEUROMODULATION MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.2 EXTERNAL NEUROSTIMULATION & NEUROMODULATION
6.2.2.1 Non-invasive procedures have ensured high interest in this field
TABLE 25 EXTERNAL NEUROSTIMULATION & NEUROMODULATION MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3 NERVE REPAIR & REGENERATION BIOMATERIALS MARKET, BY APPLICATION
TABLE 26 NERVE REPAIR & REGENERATION BIOMATERIALS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.3.1 DIRECT NERVE REPAIR/NEURORRHAPHY
TABLE 27 NERVE REPAIR AND REGENERATION BIOMATERIALS MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY TYPE, 2018-2025 (USD MILLION)
TABLE 28 NERVE REPAIR AND REGENERATION BIOMATERIALS MARKET FOR DIRECT NERVE REPAIR/NEURORRHAPHY, BY REGION, 2018-2025 (USD MILLION)
6.3.1.1 Epineural repair
6.3.1.1.1 Short operating times, ease, and minimal suturing requirements drive the demand for epineural repair
TABLE 29 EPINEURAL REPAIR MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.1.2 Perineural repair
6.3.1.2.1 Perineural repair is a highly complex surgery, which has affected its prospects in this market
TABLE 30 PERINEURAL REPAIR MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.1.3 Group fascicular repair
6.3.1.3.1 Group fascicular repair comes with a long procedural time
TABLE 31 GROUP FASCICULAR REPAIR MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2 NERVE GRAFTING
TABLE 32 NERVE REPAIR AND REGENERATION BIOMATERIALS MARKET FOR NERVE GRAFTING, BY TYPE, 2018-2025 (USD MILLION)
TABLE 33 NERVE REPAIR AND REGENERATION BIOMATERIALS MARKET FOR NERVE GRAFTING, BY REGION, 2018-2025 (USD MILLION)
6.3.2.1 Autografts
6.3.2.1.1 Autografts are considered the gold standard for nerve gap treatment
FIGURE 24 ARTICLES PUBLISHED ON AUTOGRAFTS IN NERVE REPAIR, 2010-2018
TABLE 34 AUTOGRAFTS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.2 Allografts
6.3.2.2.1 Advantages over autografts have driven market growth
FIGURE 25 ARTICLES PUBLISHED ON ALLOGRAFTS IN NERVE REPAIR, 2010-2018
TABLE 35 ALLOGRAFTS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2.3 Xenografts
6.3.2.3.1 Need for immunosuppression associated with xenograft use has restrained market growth
TABLE 36 XENOGRAFTS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.3 STEM CELL THERAPY
6.3.3.1 Low penetration of stem cell therapy is counterbalanced by high growth prospects in the future
FIGURE 26 ARTICLES PUBLISHED ON STEM CELL THERAPY IN NERVE REPAIR, 2010-2018
TABLE 37 NERVE REPAIR AND REGENERATION BIOMATERIALS MARKET FOR STEM CELL THERAPY, BY REGION, 2018-2025 (USD MILLION)
7 NERVE REPAIR AND REGENERATION MARKET, BY REGION (Page No. - 73)
7.1 INTRODUCTION
7.2 NORTH AMERICA
TABLE 39 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 40 NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 41 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 42 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 43 NORTH AMERICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 44 NORTH AMERICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 45 NORTH AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 46 NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 47 NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 48 NORTH AMERICA: BIOMATERIALS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
7.2.1 US
7.2.1.1 High prevalence of neurological disorders to increase the demand for nerve repair and regeneration products in the US
TABLE 49 US: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 50 US: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 51 US: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 52 US: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.2.2 CANADA
7.2.2.1 Rising health expenditure and increasing disease prevalence will drive market growth
TABLE 54 CANADA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 55 CANADA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 56 CANADA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 57 CANADA: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.3 EUROPE
TABLE 58 EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 59 EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 60 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 61 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 62 EUROPE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 63 EUROPE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 64 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 66 EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
7.3.1 GERMANY
7.3.1.1 Rising healthcare expenditure and favorable reimbursement policies ensure strong market growth
TABLE 68 GERMANY: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 69 GERMANY: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 70 GERMANY: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 71 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.3.2 UK
7.3.2.1 Government initiatives to drive the growth of the nerve repair and regeneration market in the UK
TABLE 72 UK: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 73 UK: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 74 UK: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 75 UK: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.3.3 FRANCE
7.3.3.1 Favorable healthcare reforms to support market growth in France
TABLE 76 FRANCE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 77 FRANCE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 78 FRANCE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 79 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.3.4 ITALY
7.3.4.1 Easy access to healthcare services has supported the use of market products
TABLE 80 ITALY: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 81 ITALY: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 82 ITALY: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 83 ITALY: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.3.5 SPAIN
7.3.5.1 Growing geriatric population and the subsequent increase in the incidence of neurological disorders to drive market growth in Spain
TABLE 84 SPAIN: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 85 SPAIN: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 86 SPAIN: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 87 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.3.6 REST OF EUROPE
TABLE 88 DEMENTIA PREVALENCE IN ROE COUNTRIES, 2018 VS. 2025
TABLE 89 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050
TABLE 90 ROE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 91 ROE: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 92 ROE: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 93 ROE: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.4 ASIA PACIFIC
TABLE 94 APAC: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 95 APAC: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 96 APAC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 97 APAC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 98 APAC: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 99 APAC: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 102 APAC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
7.4.1 JAPAN
7.4.1.1 Japan dominates the APAC market
TABLE 104 JAPAN: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 105 JAPAN: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 106 JAPAN: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 107 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.4.2 CHINA
7.4.2.1 Rising health expenditure and increased disease incidence will favor market growth
FIGURE 29 CHINA: CURRENT HEALTH EXPENDITURE, BY FINANCING SCHEME
TABLE 108 CHINA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 109 CHINA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 110 CHINA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 111 CHINA: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.4.3 INDIA
7.4.3.1 Changing government policies will have a positive impact on the market in India
TABLE 112 INDIA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 113 INDIA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 114 INDIA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 115 INDIA: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.4.4 REST OF ASIA PACIFIC (ROAPAC)
TABLE 116 ROAPAC: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 117 ROAPAC: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 118 ROAPAC: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 119 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.5 REST OF THE WORLD (ROW)
TABLE 120 ROW: NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 121 ROW: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 122 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 123 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 124 ROW: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 125 ROW: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 126 ROW: BIOMATERIALS MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 128 ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
FIGURE 30 POPULATION AGED 65 YEARS AND ABOVE (AS A PERCENTAGE OF THE TOTAL POPULATION)
FIGURE 31 POPULATION OF PEOPLE AGED 65 YEARS AND ABOVE (MILLION)
TABLE 130 LATIN AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 131 LATIN AMERICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 132 LATIN AMERICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 133 LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: INTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 136 MIDDLE EAST & AFRICA: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 137 MIDDLE EAST & AFRICA: BIOMATERIALS MARKET, BY TYPE, 2018-2025 (USD MILLION)
8 COMPETITIVE LANDSCAPE (Page No. - 120)
8.1 OVERVIEW
FIGURE 32 PRODUCT LAUNCHES-THE MOST ADOPTED GROWTH STRATEGY FROM 2017 TO 2020
8.2 MARKET SHARE ANALYSIS, 2019
FIGURE 33 SHARES OF TOP COMPANIES IN THE GLOBAL NERVE REPAIR AND REGENERATION MARKET (2019)
8.3 COMPETITIVE SCENARIO
8.3.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 138 KEY PRODUCT LAUNCHES AND APPROVALS, 2017-2020
8.3.2 PARTNERSHIPS, COLLABORATIONS, MERGERS, AND AGREEMENTS
TABLE 139 KEY PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS, 2017-2020
8.3.3 EXPANSIONS
TABLE 140 KEY EXPANSIONS, 2017-2020
8.3.4 ACQUISITIONS
TABLE 141 KEY ACQUISITIONS, 2017-2020
8.3.5 OTHER DEVELOPMENTS
TABLE 142 OTHER KEY DEVELOPMENTS, 2017-2020
8.4 COMPETITIVE LEADERSHIP MAPPING (2019)
8.4.1 VISIONARY LEADERS
8.4.2 INNOVATORS
8.4.3 DYNAMIC DIFFERENTIATORS
8.4.4 EMERGING COMPANIES
FIGURE 34 NERVE REPAIR AND REGENERATION MARKET: (GLOBAL) VENDOR COMPARISON MATRIX, 2019
9 COMPANY PROFILES (Page No. - 127)
(Business overview, Products offered, Recent Developments, MNM view)*
9.1 MEDTRONIC, PLC.
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT (2019)
9.2 BOSTON SCIENTIFIC CORPORATION
FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
9.3 ABBOTT LABORATORIES
FIGURE 37 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
9.4 AXOGEN, INC.
FIGURE 38 AXOGEN: COMPANY SNAPSHOT (2019)
9.5 BAXTER INTERNATIONAL, INC.
FIGURE 39 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2019)
9.6 LIVANOVA, PLC.
FIGURE 40 LIVANOVA: COMPANY SNAPSHOT (2019)
9.7 INTEGRA LIFESCIENCES
FIGURE 41 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2019)
9.8 POLYGANICS
9.9 NEUROPACE, INC.
9.10 SOTERIX MEDICAL, INC.
9.11 NEVRO CORP.
FIGURE 42 NERVO CORP.: COMPANY SNAPSHOT (2019)
9.12 SYNAPSE BIOMEDICAL, INC.
9.13 ALEVA NEUROTHERAPEUTICS
9.14 COLLAGEN MATRIX, INC.
9.15 KERIMEDICAL
9.16 BIOWAVE CORPORATION
9.17 NEUROSIGMA
9.18 NEURONETICS, INC.
FIGURE 43 NEURONETICS: COMPANY SNAPSHOT (2019)
9.19 TVNS TECHNOLOGIES GMBH
9.20 GIMER MEDICAL
10 APPENDIX (Page No. - 159)
10.1 INDUSTRY INSIGHTS
10.2 DISCUSSION GUIDE
10.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
10.4 AVAILABLE CUSTOMIZATIONS
10.5 RELATED REPORTS
10.6 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the nerve repair and regeneration market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Several stakeholders, such as nerve repair and regeneration manufacturers, vendors, and distributors; researchers; and doctors from hospitals and ambulatory surgery centers, were consulted for this report. The demand side of this market is characterized by significant use of nerve repair and regeneration products due to the increasing prevalence of nerve injuries and neurological disorders and the growing aging population across the globe. The supply side is characterized by advancements in technology and a shift towards advanced devices. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
Breakdown of primary participants:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the nerve repair and regeneration market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nerve repair and regeneration industry.
Report Objectives
- To define, describe, segment, and forecast the nerve repair and regenerations market on the basis of products, application, and regions
- To forecast the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
- To identify the micromarkets with respect to drivers, challenges, opportunities, and trends affecting the growth of the market
- To strategically analyze the market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the nerve repair and regenerations market
Get in-depth analysis of the COVID-19 impact on the Nerve Repair and Regeneration Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Nerve Repair and Regeneration Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Nerve Repair and Regeneration Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Nerve Repair and Regeneration Market